FOAMcast -  An Emergency Medicine Podcast

Remdesivir - A new open-label trial

08.24.2020 - By FOAMcastPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* We review Spinner et al in JAMA 2020, an open label trial of remdesivir 5 days vs remdesivir 10 days vs 'standard of care' for the treatment of #COVID19 Show notes: FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust

More episodes from FOAMcast - An Emergency Medicine Podcast